Development of novel electrospun nanofibrous scaffold from P. ricini and A. mylitta silk fibroin blend with improved surface and biological properties

• We have fabricated eri–tasar blended electrospun silk fibroin nanofiber with superior surface property.
• The hydrophilicity is higher than the silk fibroin nanofiber derived from Bombyx mori (BM).
• The nanofibrous scaffold showed improved cell adhesion and proliferation property.
• The expression of CD44 and CD29 over the MSC grown over this is substantially higher than BM.
• The metabolic activity of MSC grown over this scaffold is greater than those from BM.

Biomaterials that stimulate cell attachment and proliferation without any surface modification (e.g. RGD coating) provide potent and cost effective scaffold for regenerative medicine. This study assessed the physico-chemical properties and cell supportive potential of a silk fibroin blend scaffold derived from eri (Philosamia ricini) and tasar (Antheraea mylitta) silk (ET) respectively by electrospinning process. The scanning electron microscopy and transmission electron microscopy study found that the fiber diameters are in 200 to 800 nm range with flat morphology. The porosity of ET scaffold is found to be 79 ± 5% with majority of pore diameter between 2.5 to 5 nm. Similarly, Bombyx mori (BM) silk fibroin and gelatin nanofibrous scaffolds were prepared and taken as control. The ultimate tensile strength of the ET and BM scaffold are found to be 1.83 ± 0.13 MPa and 1.47 ± 0.10 MPa respectively. The measured contact angle (a measure of hydrophilicity) for ET (54.7° ± 1.8°) is found to be lower than BM (62° ± 2.3°). The ability to deposit apatite over ET is comparable to that of BM nanofibers. All the scaffolds were seeded with cord blood derived mesenchymal stem cells (hMSCs) and cultured for 14 days in vitro. The immunofluorescence study reveals enhanced cell attachment with higher metabolic activity for MSCs grown over ET than BM and gelatin. The ET scaffold also demonstrated expression of higher amount cell adhesion molecules (CD29/CD44) and higher proliferation rate than BM and gelatin as confirmed by MTT assay, DNA content estimation assay, flow cytometry study and SEM study. Overall, it may be concluded that ET scaffold may have potential in developing bone tissue grafts for clinical applications in the future.